Clinical Trials

All Clinical Trials

Exploring Patterns of Care among American Indian Children with Cancer Protocol Number: 1-AI-CARE
Status: Open

View Details
REACT: Prevention and Treatment of Vasospasm with Clazosentan A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Phase 3 Study to Assess the Efficacy and Safety of Clazosentan in Preventing Clinical Deterioration Due to Delayed Cerebral Ischemia (DCI), in Adult Subjects with Aneurysmal Subarachnoid Hemorrhage (aSAH) Protocol Number: 10024
Status: Open

View Details
Predictive Value of Pulmonary Artery Acceleration Time, Inflammatory Biomarkers, Endothelin 1, Rho-Kinase and B-Natriuretic Peptide in the Development of Pulmonary Hypertension as a Result of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: An Observational Pilot Study. Protocol Number: 10099
Status: Open

View Details
PROSpect: Prone and Oscillation Pediatric Clinical Trial Protocol Number: 10562
Status: Open

View Details
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Protocol Number: 10600
Status: Open

View Details
A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease Protocol Number: 10603
Status: Open

View Details
Does Insulin Sensitivity Impact the Potential of Metformin to Slow Aging Protocol Number: 10699
Status: Open

View Details
A Multi-Center, Parallel-Group, Randomized Controlled Trial of Frozen Embryo Transfers to Determine Incidence of Preeclampsia and Live Birth Rate in Modified Natural versus Programmed Cycles (NATPRO) Protocol Number: 10846
Status: Open

View Details
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohns disease Protocol Number: 11254
Status: Open

View Details
Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery Protocol Number: 11294
Status: Open

View Details
Stress Hydrocortisone in Pediatric Septic Shock Protocol Number: 11451
Status: Open

View Details
Pharmacokinetics, Pharmcodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care / (POPS) Protocol Number: 11513
Status: Open

View Details
Evaluating the Relationship between Ovarian Reserve and Facial Age as Determined by Computer Software in Non-Infertile Population Protocol Number: 11568
Status: Open

View Details
READY 1: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO CONTROLLED STUDY ON THE USE OF CUSA-081 FOR DYSFUNCTIONAL CENTRAL VENOUS ACCESS DEVICES (CVADs) Protocol Number: 11706
Status: Open

View Details
Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype Prospective Outcomes (ILD-PRO) Registry Protocol Number: 11858
Status: Open

View Details